Home-based Macular Degeneration Monitoring Appears Cost Effective
Thursday, April 06, 2017 | Medical Studies
Home telemonitoring of people at risk for age-related macular degeneration (AMD) is potentially cost-effective, according to an economic analysis using a simulation model. As Dr. John S. Wittenborn explained, "The emergence of anti-VEGF treatment for wet-form AMD has had a dramatic impact on preserving vision for many Americans. However, community studies universally show that self-referral is surprisingly low and most patients are not diagnosed with wet-form AMD until they have already lost a significant, and largely unrecoverable amount of their vision."